Sobi presents positive results from EMBRACE phase...
Category : Clinical Trial Update 20 March 2026Sobi, a global biopharma company unlocking the potential of breakthrough innovations, transforming e...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
US FDA grants Breakthrough Therapy designation to...
Category : ODD/BTA/FTA Status 20 March 2026Sanofi announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy des...
Rhythm’s EMANATE Trial Misses the Mark—But Not the...
Category : Clinical Trial Update 19 March 2026Drug development rarely fails cleanly. Sometimes, the headline says “missed endpoints,”...
Aspen Neuroscience’s Cell Therapy Shows Early Prom...
Category : Clinical Trial Update 19 March 2026Most Parkinson’s treatments manage symptoms. They don’t fix the underlying damage. Now,...
A New Playbook for Ulcerative Colitis: Drugs + Nut...
Category : Clinical Trial Update 19 March 2026Most ulcerative colitis treatments follow a familiar pattern: Start with drugs. Escalate if needed....
Latest Newsletter Post
-
US FDA grants Breakthrough Therapy..
20 March 2026
-
Sobi presents positive results from..
20 March 2026
-
A New Playbook for Ulcerative Colit..
19 March 2026
-
Aspen Neuroscience’s Cell Therapy S..
19 March 2026
-
Rhythm’s EMANATE Trial Misses the M..
19 March 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com